Trials / Sponsors / Neumedicines Inc.
Neumedicines Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemother Lymphoma, Large B-Cell, Diffuse (DLBCL) | Phase 2 | 2016-11-01 |
| Completed | NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds Colostomy Stoma | Phase 2 | 2016-03-01 |
| Unknown | NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides, Sézary Syndrome | Phase 2 | 2015-12-01 |
| Completed | Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome Hematopoietic Syndrome Due to Acute Radiation Syndrome | Phase 2 | 2015-01-01 |
| Completed | Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure Hematopoietic Syndrome Due to Acute Radiation Syndrome | Phase 1 | 2012-08-01 |